Medtronic has inked a five-year deal to sell Kuros Biosciences’ MagnetOs bone graft technology for use in spine procedures in the U.S.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,